Intracranial Stents Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

A mesh-like tube-shaped object that is made of nitinol is called a stent. The stent used for intracranial pathology is self-expanding in nature. Balloon expanding stents, self-expanding stents, and stent-assisted coil embolization are the types of intracranial stents. The intracranial stents are majorly used for treating intracranial stenosis and brain aneurysms. Intracranial stenosis is narrowing of brain blood vessels majorly due to atherosclerosis, which helps in building plaques or blood clots. Atherosclerosis happens when fatty deposits build on the inside of arteries. They make the arteries narrower and harder, making them more likely to become blocked. Brain aneurysms are thin or weak spots on the wall of a blood vessel in the brain that balloons out and fills with blood. The intracranial stents open up the blood vessels by making a way for the blood to pass.

The growing prevalence of chronic neurological diseases and the rising geriatric population are some key factors contributing toward the growth of the intracranial stents market globally. Moreover, innovation in technology for intracranial stents and an increasing number of research activities for the development of advanced stents are boosting the growth of the intracranial stents market globally. However, the high cost of embolization coils and lack of skilled procession may hamper the intracranial stents market in developing and underdeveloped countries.

The global intracranial stents market is segmented into product type, disease indication, and end-user. By product type, the global intracranial stents market is segmented into balloon expanding stents, self-expanding stents, and stent-assisted coil embolization. By disease indication, the market is segmented into brain aneurysm and intracranial stenosis. By end-user, the market is segmented into ambulatory surgery centers, hospitals, and others.

By region, North America dominated the global intracranial stents market in 2018 and is anticipated to remain dominant over the forecast time period as well. This can be attributed to the presence of a large geriatric population that is prone to strokes and the high adoption of technically advanced products in the region. The Asia Pacific intracranial stents market is expected to register a high rate of growth in the future, owing to a large base of geriatric population in Japan and intracranial diseases being the second most common cause of death for people above the age of 60.

Some key players of the global intracranial stents market are Acandis, Penumbra, Inc., MicroPort Scientific, Medtronic, Phenox, Stryker Corporation, Boston Scientific Corporation, DePuy Synthes, Cook Medical, and Terumo Corporation, among others.